Commentary: Improved patient outcomes remain elusive after intensive imaging surveillance for high-risk melanoma - 17/08/16
Doi : 10.1016/j.jaad.2016.05.010
Susan M. Swetter, MD ⁎ 
Dermatology Service, Department of Veterans Affairs Palo Alto Health Care System, Palo Alto, California
Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California
∗Correspondence to: Susan M. Swetter, MD, Dermatology/Cutaneous Oncology, Stanford University Medical Center and Cancer Institute, 900 Blake Wilbur Dr, W3045, Stanford, CA 94305.Dermatology/Cutaneous OncologyStanford University Medical Center and Cancer Institute900 Blake Wilbur Dr, W3045StanfordCA94305
Key words : computed tomography, follow-up studies, melanoma, metastasis, recurrence, ultrasonography
Abbreviations used : AJCC, CT, LN, MRI, NCCN, OS, SLNB
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the author. |
© 2016
Publié par Elsevier Masson SAS.
Vol 75 - N° 3
P. 525-527 - septembre 2016 Retour au numéro
Article précédent
- Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study
- Sebastian Podlipnik, Cristina Carrera, Marcelo Sánchez, Pedro Arguis, Maria L. Olondo, Ramon Vilana, Ramon Rull, Sergi Vidal-Sicart, Antonio Vilalta, Carles Conill, Josep Malvehy, Susana Puig
- Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration–approved systemic therapies
- Jessica R. Walter, Shuai Xu, Amy S. Paller, Jennifer N. Choi, Teresa K. Woodruff
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?